课题基金 / 基金详情

Neuropharmacological studies of clustering molecules expressing in the excitatory synapses

Neuropharmacological studies of clustering molecules expressing in the excitatory synapses
兴奋性突触中表达的聚类分子的神经药理学研究
批准号:
11470025
负责人:
FUKUNAGA Kohji
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

FUKUNAGA Kohji的其他基金

相似基金

相关文献

中文摘要
翻译
已经克隆并表征了椎间盘大(dlg)肿瘤抑制蛋白的人同源物NE-dlg(神经元和内分泌-dlg)(K. Makino等人,Oncogene,14,2425,1997)。NE-dlg,也称为SAP 102,与NMDA受体2B(NR 2B)相互作用以使受体聚集在突触后密度中。我们首先证明了NE-dlg与钙调蛋白和PSD-95在体外相互作用(J. Biol. Chem.,274,5782,1999)。我们还在大脑中发现了一种相互作用的蛋白质,p51-Nedasin。P51-Nedasin干扰NE-dlg和NR 2B之间的结合(J.Biol.Chem.274,32204,1999)。接下来,我们证明了在体外和原位磷酸化NE-dlg的钙调素激酶II在突触后密度组分和培养的大鼠海马神经元。在海马长时程增强后也观察到NE-dlg磷酸化增加。用CaM激酶抑制剂KN 93处理可阻止磷酸化增加,但蛋白激酶C抑制剂不能。我们评估了NE-dlg磷酸化的功能相关性。CaM激酶II依赖的NE-dlg磷酸化阻止其与NR 2B结合,但促进NR 2B和NR 1在突触后致密物中的积累。关于NE-dlg的胞质定位,CaM激酶II对NE-dlg的磷酸化可能参与NR 2B和/或NR 1向突触后致密物的转运。我们最近发现,CaM激酶II也参与多巴胺D2受体从高尔基体转运到神经元的质膜,其中支架蛋白如NE-dlg可能是其转运机制的基础。
英文摘要
A human homologue to the discs large (dlg) tumor suppresser protein, NE-dlg (neuronal and endocrine-dlg) has been cloned and characterized (K. Makino et al., Oncogene, 14, 2425, 1997). NE-dlg, also named SAP102, interacts with the NMDA receptor 2B (NR2B) to cluster the receptors in the postsynaptic density. We first documented that NE-dlg interacts with calmodulin and PSD-95 in vitro (J. Biol. Chem., 274, 5782, 1999). We also found an interacting protein, p51-Nedasin, in the brain. The P51-Nedasin interferes the association between NE-dlg and NR2B (J. Biol. Chem. 274, 32204, 1999). We next demonstrated in vitro and in situ phosphorylation of NE-dlg by CaM kinase II in the postsynaptic density fractions and in cultured rat hippocampal neurons. An increased phosphorylation of NE-dlg was also observed following hippocampal long-term potentiation. The increased phosphorylation was prevented by treatment with KN93, a CaM kinase inhibitor but not by protein kinase C inhibitors. We assessed the functional relevance of NE-dlg phosphorylation. CaM kinase Il-dependent NE-dlg phosphorylation prevented its binding to NR2B but promoted the accumulation of NR2B and NR1 in the postsynaptic density. As concerning the cytoplasmic localization of NE-dlg, the phosphorylation of NE-dlg by CaM kinase II is possibly involved in the transport of NR2B and/or NR1 into the postsynaptic density. We recently found that CaM kinase II is also involved in transport of dopamine D2 receptors from Golgi apparatus to the plasma membrane in the neurons, in which a scaffold protein like NE-dlg may underlie its transport mechanisms.
期刊论文(172)
专著(0)
科研奖励(0)
会议论文
H.Kanasaki, K.Fukunaga, K.Takahashi, K.Miyazaki and E.Miyamoto: "Mitogenactivated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells."Biol.Reprod.. 61. 319-325 (1999)
H.Kanasaki、K.Fukunaga、K.Takahashi、K.Miyazaki 和 E.Miyamoto:“通过在大鼠垂体 GH3 细胞中用促甲状腺素释放激素刺激来激活丝裂原活化蛋白激酶。”Biol.Reprod.. 61. 319-325 (
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M Morioka, K. Fukunaga, Y. Kai, T. Todaka, S. Yano, J. Hamada, E. Miyamoto and Y. Ushio: "Intravenously injected FK506 failed to inhibit hippocampal calcineurin"Biochem. Biophys. Res. Commun.. 286. 802-806 (2001)
M Morioka、K. Fukunaga、Y. Kai、T. Todaka、S. Yano、J. Hamada、E. Miyamoto 和 Y. Ushio:“静脉注射 FK506 未能抑制海马神经钙蛋白”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
J.Kasahara: "Activation of Ca^<2+>/calmodulin-dependent protein kinase IV in cultured rat hippocampal neurons"J. Neurosci. Res.. 59. 594-600 (2000)
J.Kasahara:“培养的大鼠海马神经元中Ca^2/钙调蛋白依赖性蛋白激酶IV的激活”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. Fukunaga and E. Miyamoto: "A working model of CaM kinase II activity in hippocampal long-term potentiation and memory"Neurosci. Res.. 38. 3-17 (2000)
K. Fukunaga 和 E. Miyamoto:“海马长时程增强和记忆中 CaM 激酶 II 活性的工作模型”Neurosci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 85 条
    Role of fatty acid-binding protein in the brain vulnerability in schizophrenia
    • 批准号:
      22659012
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.92万
    • 财政年份:
      2010
    • 负责人:
      FUKUNAGA Kohji
    • 依托单位:
    Drug development targeting for regeneration of neurovascular units in neurodegenerative disorders
    • 批准号:
      22390109
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2010
    • 负责人:
      FUKUNAGA Kohji
    • 依托单位:
    Development of novel neuroprotective drugs targeting for neurovascular unit therapy.
    • 批准号:
      19390150
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2007
    • 负责人:
      FUKUNAGA Kohji
    • 依托单位:
    Drug development by signal transduction therapy in the ischemic brain injury.
    • 批准号:
      14370035
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.49万
    • 财政年份:
      2002
    • 负责人:
      FUKUNAGA Kohji
    • 依托单位:
    海外基金